JNK and p38 Inhibitors Prevent Transforming Growth Factor-β1-Induced Myofibroblast Transdifferentiation in Human

Tzu-Yu Hou1,2,3, Shi-Bei Wu4, Hui-Chuan Kau1,2,3,5

  • 1Department of Ophthalmology, Taipei Veterans General Hospital, Taipei 112, Taiwan.

Insights

Transforming growth factor-β1 (TGF-β1) activates Graves

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Biology

Background:

  • Graves' ophthalmopathy (GO) involves tissue remodeling and fibrosis driven by transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation.
  • The precise signaling pathways mediating TGF-β1 activation of orbital fibroblasts in GO are not fully understood.

Purpose of the Study:

  • To investigate the role of the mitogen-activated protein kinase (MAPK) pathway in TGF-β1-induced myofibroblast transdifferentiation in human Graves' orbital fibroblasts.

Main Methods:

  • Western blots were used to measure the phosphorylation of p38, c-Jun N-terminal kinase (JNK), and extracellular-signal-regulated kinase (ERK).
  • Expression of fibrogenic markers (CTGF, α-SMA, fibronectin) and extracellular matrix (ECM) regulators (MMPs, TIMPs) was analyzed.
  • Pharmacologic kinase inhibitors targeting the MAPK pathway were employed to validate findings.

Main Results:

  • TGF-β1 treatment increased phosphorylation of p38 and JNK, but not ERK.
  • Fibrogenic markers (CTGF, α-SMA, fibronectin) and TIMP-1/TIMP-3 were upregulated, while MMP-2/-9 activity decreased.
  • Inhibition of p38 and JNK pathways abolished TGF-β1-induced changes in marker expression.

Conclusions:

  • TGF-β1 induces myofibroblast transdifferentiation in human Graves' orbital fibroblasts.
  • The p38 and JNK signaling pathways are critical mediators of this TGF-β1-induced process.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.4K
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.1K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.3K